Device Trial Radar · NCT06909539
HOme PElvic Floor Improvement Trainer Trial
Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
150
Planned (sponsor's estimate)
Start
Nov 1, 2026
Primary completion
Nov 1, 2028
Study completion Nov 1, 2028
Sponsor
- Lead sponsor
- University of Colorado, DenverAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 3, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 8 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will gauge the efficacy of a home biofeedback treatment device for pelvic floor dysfunction/voiding dysfunction and pelvic pain. Investigators will test the utility of this device as a treatment alternative and/or temporary treatment for a patient's symptoms prior to or perhaps in lieu of their physical therapy appointment.
Conditions
- Pelvic Pain
- Pelvic Floor Dysfunction
- Voiding Dysfunction
Interventions
Home Pelvic Floor TrainerDevice
The intervention utilizes a perineometer device with biofeedback features. This device employs external electrodes to measure pelvic floor muscle strength. It then provides real-time feedback through a smartphone application during exercise sessions. The application uses gamification to engage users and track progress. Patients can choose between two games: a bird game or a space-themed game. In the bird game, patients activate their pelvic floor muscles to make the bird fly upward. In the space game, pelvic floor contractions fire a laser or activate a shield. A visual bar displays the strength of pelvic floor contractions. Games are designed to be played for 5 minutes daily, 7 days a week, with increasing difficulty as the user progresses through levels.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dysfunctional Voiding Symptom Scale (30 point scale)Time frame: 0 weeks baseline, 4 weeks, and 8 weeks patients will take the DVSS survey
- McGill Pain Scale (Short Form - points scale)Time frame: 0 weeks baseline, 4 weeks, and 8 weeks patients will take the McGill Pain Scale Short Form survey
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Colorado Anschutz
Aurora, Colorado · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.